These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


PUBMED FOR HANDHELDS

Journal Abstract Search


463 related items for PubMed ID: 28141782

  • 1. Effect of Pregnancy on Interferon Gamma Release Assay and Tuberculin Skin Test Detection of Latent TB Infection Among HIV-Infected Women in a High Burden Setting.
    LaCourse SM, Cranmer LM, Matemo D, Kinuthia J, Richardson BA, Horne DJ, John-Stewart G.
    J Acquir Immune Defic Syndr; 2017 May 01; 75(1):128-136. PubMed ID: 28141782
    [Abstract] [Full Text] [Related]

  • 2. Prevalence of latent tuberculosis infection in persons with and without human immunodeficiency virus infection using two interferon-gamma release assays and tuberculin skin test in a low human immunodeficiency virus prevalence, intermediate tuberculosis-burden country.
    Lin WC, Lin HH, Lee SS, Sy CL, Wu KS, Chen JK, Tsai HC, Chen YS.
    J Microbiol Immunol Infect; 2016 Oct 01; 49(5):729-736. PubMed ID: 25442858
    [Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Performance of QuantiFERON-TB Gold Plus for detection of latent tuberculosis infection in pregnant women living in a tuberculosis- and HIV-endemic setting.
    König Walles J, Tesfaye F, Jansson M, Tolera Balcha T, Winqvist N, Kefeni M, Garoma Abeya S, Belachew F, Sturegård E, Björkman P.
    PLoS One; 2018 Oct 01; 13(4):e0193589. PubMed ID: 29617458
    [Abstract] [Full Text] [Related]

  • 7. Effect of pregnancy and HIV infection on detection of latent TB infection by Tuberculin Skin Test and QuantiFERON-TB Gold In-Tube assay among women living in a high TB and HIV burden setting.
    Birku M, Desalegn G, Kassa G, Tsegaye A, Abebe M.
    Int J Infect Dis; 2020 Dec 01; 101():235-242. PubMed ID: 33039610
    [Abstract] [Full Text] [Related]

  • 8. Poor agreement between interferon-gamma release assays and the tuberculin skin test among HIV-infected individuals in the country of Georgia.
    Chkhartishvili N, Kempker RR, Dvali N, Abashidze L, Sharavdze L, Gabunia P, Blumberg HM, Del Rio C, Tsertsvadze T.
    BMC Infect Dis; 2013 Nov 01; 13():513. PubMed ID: 24176032
    [Abstract] [Full Text] [Related]

  • 9. Quantitative IFN-γ and IL-2 Response Associated with Latent Tuberculosis Test Discordance in HIV-infected Pregnant Women.
    Mathad JS, Bhosale R, Balasubramanian U, Kanade S, Mave V, Suryavanshi N, Gupte N, Joshi S, Chandanwale A, Dupnik KM, Kulkarni V, Deshpande P, Fitzgerald DW, Gupta A.
    Am J Respir Crit Care Med; 2016 Jun 15; 193(12):1421-8. PubMed ID: 26765255
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Comparison of QuantiFERON-TB Gold test and tuberculin skin test for the identification of latent Mycobacterium tuberculosis infection in lupus patients.
    Yilmaz N, Zehra Aydin S, Inanc N, Karakurt S, Direskeneli H, Yavuz S.
    Lupus; 2012 Apr 15; 21(5):491-5. PubMed ID: 22140142
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14. QuantiFERON conversion following tuberculin administration is common in HIV infection and relates to baseline response.
    Esmail H, Thienemann F, Oni T, Goliath R, Wilkinson KA, Wilkinson RJ.
    BMC Infect Dis; 2016 Oct 07; 16(1):545. PubMed ID: 27717329
    [Abstract] [Full Text] [Related]

  • 15. Performance of the QuantiFERON®-TB Gold In-Tube assay in tuberculin skin test converters: a prospective cohort study.
    Castellanos ME, Kirimunda S, Martinez L, Quach T, Woldu H, Kakaire R, Handel A, Zalwango S, Kiwanuka N, Whalen CC.
    Int J Tuberc Lung Dis; 2018 Sep 01; 22(9):1000-1006. PubMed ID: 30092864
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. QuantiFERON-TB Gold In-Tube Test for Tuberculosis Prevention in HIV-Infected Patients.
    Khawcharoenporn T, Phetsuksiri B, Rudeeaneksin J, Srisungngam S, Apisarnthanarak A.
    Jpn J Infect Dis; 2017 Sep 25; 70(5):502-506. PubMed ID: 28367883
    [Abstract] [Full Text] [Related]

  • 18. Dual latent tuberculosis screening with tuberculin skin tests and QuantiFERON-TB assays before TNF-α inhibitor initiation in children in Spain.
    Calzada-Hernández J, Anton J, Martín de Carpi J, López-Montesinos B, Calvo I, Donat E, Núñez E, Blasco Alonso J, Mellado MJ, Baquero-Artigao F, Leis R, Vegas-Álvarez AM, Medrano San Ildefonso M, Pinedo-Gago MDC, Eizaguirre FJ, Tagarro A, Camacho-Lovillo M, Pérez-Gorricho B, Gavilán-Martín C, Guillén S, Sevilla-Pérez B, Peña-Quintana L, Mesa-Del-Castillo P, Fortuny C, Tebruegge M, Noguera-Julian A.
    Eur J Pediatr; 2023 Jan 25; 182(1):307-317. PubMed ID: 36335186
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Tuberculin skin test and QuantiFERON-Gold In Tube assay for diagnosis of latent TB infection among household contacts of pulmonary TB patients in high TB burden setting.
    Chandrasekaran P, Mave V, Thiruvengadam K, Gupte N, Shivakumar SVBY, Hanna LE, Kulkarni V, Kadam D, Dhanasekaran K, Paradkar M, Thomas B, Kohli R, Dolla C, Bharadwaj R, Sivaramakrishnan GN, Pradhan N, Gupte A, Murali L, Valvi C, Swaminathan S, Gupta A, CTRIUMPH Study Team.
    PLoS One; 2018 Jan 25; 13(8):e0199360. PubMed ID: 30067752
    [Abstract] [Full Text] [Related]


    Page: [Next] [New Search]
    of 24.